enVVeno Medical Corp

NVNO

enVVeno Medical Corp

NVNO

Insider Sentiment (TTM):

Last Purchase:2024-12-31Last Sale:2026-06-11Shares Purchased (TTM):0Shares Sold (TTM):10,080

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:95,299Shares Outstanding:654,000Institutional Ownership Pct.:14.57%

Earnings Market Reaction:

Filing Date:2026-07-30Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Cash And Cash Equivalents At Carrying Value	3	3	3	2	2	3	2	18	2	2	4	5
Assets Current
Assets Current	22	25	29	31	36	39	44	49	40	43	47	26
Short Term Investments	19	22	25	29	33	36	41	30	37	41	43	21
Prepaid Expense And Other Assets Current	1	1	1	1	0	1	1	1	0	0	1	1
Property Plant And Equipment Net	0	0	0	0	0	0	0	0	0	0	0	0
Operating Lease Right Of Use Asset	0	1	1	1	1	1	1	1	1	1	1	1
Assets	23	26	30	32	37	41	45	50	41	45	49	28
Liabilities And Stockhold…
Accounts Payable Current	-	-	-	-	-	-	-	-	-	-	-	2
Accounts Payable And Accrued Liabilities Current	-	-	-	2	3	1	2	2	1	1	1	-
Liabilities Current
Liabilities Current	2	2	2	2	3	2	2	2	2	1	1	2
Accounts Payable And Other Accrued Liabilities Cur…	1	2	2	-	-	-	2	-	-	-	-	-
Operating Lease Liability Current	0	0	0	0	0	0	0	0	0	0	0	0
Operating Lease Liability Noncurrent	0	0	0	1	1	1	1	1	1	1	1	1
Liabilities	2	2	2	3	4	2	3	3	3	2	2	3
Stockholders Equity
Stockholders Equity	21	24	27	29	33	38	42	47	38	42	46	25
Additional Paid In Capital	199	199	198	197	196	195	194	193	178	177	176	149
Retained Earnings Accumulated Deficit	-179	-175	-171	-168	-163	-156	-152	-146	-140	-135	-130	-124
Liabilities And Stockholders Equity	23	26	30	32	37	41	45	50	41	45	49	28
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	10
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	250	250	250	250	250	250	250	250	250	250	250	250
Common Stock Shares Issued	1	1	1	20	19	18	1	18	13	13	13	9
Shares Outstanding	1	1	1	20	19	18	1	18	13	13	13	9

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	12.51%	7.65%	3.18%	-	-	-	-	-	-	-	-	-
2025	11.67%	35.00%	65.67%	-78.31%	-79.76%	-83.90%	-52.94%	-54.09%	-50.93%	11.32%	-6.66%	-4.85%
2024	-6.47%	2.94%	12.75%	2.42%	-11.71%	-38.10%	1.19%	-26.11%	-2.37%	-6.29%	-22.96%	13.84%
2023	-	-	-	-14.63%	3.25%	8.74%	-18.64%	-17.67%	-20.78%	-9.31%	-25.84%	-19.90%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	11.70	11.89	13.58	13.12	11.81	23.77	20.88	22.01	23.33	29.08	34.23	12.91
Quick Ratio	11.39	11.63	13.30	12.90	11.66	23.44	20.60	21.70	23.05	28.88	33.85	12.65
Working Capital	20.20M	23.35M	26.70M	29.10M	32.59M	37.82M	41.64M	46.82M	37.84M	41.76M	45.55M	24.19M
Leverage & Debt
Debt to Equity	0.10	0.10	0.09	0.10	0.11	0.06	0.07	0.06	0.07	0.06	0.05	0.13
Debt Ratio	0.09	0.09	0.08	0.09	0.10	0.06	0.06	0.06	0.06	0.05	0.05	0.11
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-23.43	-28.77	-33.06	-1.09	-39.70	-36.71	-44.53	-1.32	-1.28	-1.38	-1.91	-2.14
Free Cash Flow Per Share TTM	-21.79	-22.62	-26.44	-0.86	-29.49	-29.83	-34.44	-1.04	-1.04	-1.08	-1.54	-1.58
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	-31.84%	-11.78%	-10.76%	3.42%	11.99%	-3.55%	-7.22%	-11.68%	-18.08%	-14.05%	-4.67%	-12.48%
EPS Growth (1Y)	-40.98%	-21.62%	-25.76%	-17.56%	2,997.02%	2,565.46%	2,229.25%	-38.26%	-42.73%	-39.88%	-12.97%	-12.50%
Valuation Metrics
P/E TTM	-0.46	-0.35	-0.34	-29.10	-3.52	-2.51	-2.37	-88.96	-143.33	-138.24	-94.10	-88.11
P/B TTM	0.35	0.28	0.24	21.70	2.45	1.40	1.23	39.89	76.85	72.16	47.90	85.04
Market Cap	7.19M	6.63M	6.62M	639.12M	81.14M	53.48M	51.79M	1.89B	2.95B	3.06B	2.21B	2.12B
Enterprise Value	4.35M	4.03M	3.55M	637.57M	79.09M	50.54M	50.04M	1.87B	2.95B	3.05B	2.21B	2.11B
Calculated Values
Free Cash Flow TTM	-14.62M	-14.79M	-15.57M	-17.24M	-17.13M	-17.33M	-16.88M	-16.74M	-16.67M	-17.34M	-18.89M	-17.78M
Net Debt	-2.84M	-2.60M	-3.07M	-1.54M	-2.04M	-2.94M	-1.75M	-17.92M	-2.38M	-2.31M	-3.62M	-4.95M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-11Sale

Owner: Duhay, Francis

Title: -

Shares: 140

Price/Share: $10.31

Value: $1,443.40

Shares Owned: 2,362

Relationship: Director

Ownership: Direct

2026-03-12Sale

Owner: Duhay, Francis

Title: -

Shares: 140

Price/Share: $11.52

Value: $1,612.80

Shares Owned: 2,502

Relationship: Director

Ownership: Direct

2025-12-11Sale

Owner: Duhay, Francis

Title: -

Shares: 4,900

Price/Share: $0.36

Value: $1,764.00

Shares Owned: 92,544

Relationship: Director

Ownership: Direct

2025-09-15Sale

Owner: Duhay, Francis

Title: -

Shares: 4,900

Price/Share: $0.83

Value: $4,067.00

Shares Owned: 97,444

Relationship: Director

Ownership: Direct

2024-12-31Purchase

Owner: Duhay, Francis

Title: -

Shares: 81,433

Price/Share: $3.07

Value: $249,999.31

Shares Owned: 102,344

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-11	Duhay, Francis	Director	-	Direct	Sale	140	10.31	$1,443.40	2,362	4
2026-03-12	Duhay, Francis	Director	-	Direct	Sale	140	11.52	$1,612.80	2,502	4
2025-12-11	Duhay, Francis	Director	-	Direct	Sale	4,900	0.36	$1,764.00	92,544	4
2025-09-15	Duhay, Francis	Director	-	Direct	Sale	4,900	0.83	$4,067.00	97,444	4
2024-12-31	Duhay, Francis	Director	-	Direct	Purchase	81,433	3.07	$249,999.31	102,344	4
2024-12-31	Gray, Robert	Director	-	Direct	Purchase	3,500	2.94	$10,290.00	11,155	4
2024-12-24	Shrivastava, Sanjay	Director	-	Direct	Purchase	5,400	2.90	$15,660.00	9,288	4
2024-12-19	Berman, Robert Andrew	Director,Officer	Chief Executive Officer	Direct	Purchase	12,000	2.55	$30,600.00	222,236	4
2024-12-19	Jenusaitis, Matthew	Director	-	Direct	Purchase	9,620	2.53	$24,338.60	16,545	4
2024-03-13	Alavi, Hamed	Officer	Chief Technology Officer	Direct	Sale	8,334	6.22	$51,837.48	0	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

14.57%

Inst. Shares: 95,299

Shares Outstanding: 654,000

2025-12-31

Inst. Shares: 6,224,866

Shares Outstanding: 589,000

2025-09-30

29.13%

Inst. Shares: 5,870,986

Shares Outstanding: 20,155,000

2025-06-30

Inst. Shares: 5,068,294

Shares Outstanding: 581,000

2025-03-31

Inst. Shares: 3,640,381

Shares Outstanding: 581,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	95,299	654,000	14.57%
2025-12-31	6,224,866	589,000	-
2025-09-30	5,870,986	20,155,000	29.13%
2025-06-30	5,068,294	581,000	-
2025-03-31	3,640,381	581,000	-
2024-12-31	4,234,765	490,000	-
2024-09-30	5,209,889	16,067,000	32.43%
2024-06-30	3,274,715	16,067,000	20.38%
2024-03-31	3,589,074	16,057,000	22.35%
2023-12-31	3,848,731	12,301,000	31.29%
2023-09-30	1,910,703	11,231,000	17.01%
2023-06-30	1,888,085	11,231,000	16.81%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

enVVeno Medical Corp (NVNO) — SEC Financial Statements & Analysis

enVVeno Medical Corp (NVNO) is a surgical & medical instruments & apparatus company, incorporated in DE. enVVeno Medical Corp trades on Nasdaq as: NVNO. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), enVVeno Medical Corp reported a Debt-to-Equity ratio of 0.10x, a Price-to-Book (P/B) ratio of 0.35x (TTM), at a market cap of $7.19M. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: 0.10x
P/B TTM: 0.35x
Market Cap: $7.19M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is enVVeno Medical Corp in?

enVVeno Medical Corp (NVNO) operates in the Surgical & Medical Instruments & Apparatus industry.

What is NVNO's market cap?

enVVeno Medical Corp (NVNO) has a market capitalization of $7.19M as of 2026-06-30.

What exchange does NVNO trade on?

enVVeno Medical Corp (NVNO) trades on the Nasdaq.

Where is enVVeno Medical Corp incorporated?

enVVeno Medical Corp is incorporated in DE.